STUDY OF CLINICAL AND LABORATORY CHARACTERISTICS IN HUMAN TOXOCARIASIS AT MEDIC MEDICAL CENTER IN HO CHI MINH CITY, 2018 - 2019
Main Article Content
Abstract
Toxocariasis is a zoonotic helminthiasis caused by the migrating larvae of Toxocara canis and Toxocara cati, common roundworms of dogs and cats and becoming the problem of the public health. The clinical diagnosis of human toxocariasis is difficult because of the nonspecific clinical presentation, may lead to prolonged morbidity and development of health complications.
Objectives: The study was conducted to describe clinical symptoms, laboratory changes in patients with Toxocara spp. infection.
Methods: Cross-sectional descriptive study and analysis.
Results: The mean age was 41 ± 15 years old, the age group 20 - < 60 years old accounted for 75.9%. The distribution of females was higher than that of males. The most common symptoms were in the skin (77.5%), followed by neurological manifestations (35.0%), digestive (31.7%) and respiratory manifestations (21.7%). All patients had an increase in the number of eosinophils in the peripheral blood, but 91.7% had a mild increase (from 500 - < 1,500 cells/mm3). The mean total serum IgE concentration was 764.7 ± 630.6 IU/mL, 43.3% of patients had an IgE increase less than 4 times the limit of normal (from 130 - < 520 IU/mL). The mean optical density of anti-Toxocara spp. IgG was 1.51 ± 0.85, the value distribution from 0.36 to 3.50.
Conclusion: Clinical symptoms of human toxocariasis were diverse and manifest in many organs. The peripheral blood eosinophils, serum total IgE levels and anti-Toxocara spp. IgG were important laboratory parameters for diagnosis of toxocariasis in humans.
Article Details
Keywords
Human toxocariasis, eosinophils, total IgE levels, anti-Toxocara spp. IgG.
References
[2] Chuong NV, Quang HH, Tuan BV, Study of several clinical, paraclinical characteristics on Human toxocariasis in Central Highlands of Vietnam and treatment efficiency of albendazole. Journal of prevention from malaria and parasitic diseases, 2014, 4:3-13.
[3] Pawlowski Z, Toxocariasis in humans: Clinical expression and treatment dilemma. Journal of Helminthology, 2001, 75(4):299-305.
[4] Phuc LDV, Study on clinical and paraclinical epidemiological characteristics of patients with serum in diagnosing positive Toxocara spp. and the prevalence of Toxocariasis under case definition of Pawlowski. Vietnam Journal of Infectious Diseases, Edition 2014, 3(7):21-5.
[5] Ministry of Health, Decision No. 4283/QĐ-BYT dated 8/8/2016 on Documents defining the cases of infectious diseases, 2016.
[6] De NV, Minh PN, Lien PH et al., Clinical manifestations of human toxocariasis and species identification by molecular biology of toxocara species on human. Journal of prevention from malaria and parasitic diseases (The 41th scientific special subject and training conference on parasite of the whole country), 2014, 49-54.
[7] Binh DN, Thang DV, Nam LV et al., The initial evaluation ò results after one treatment month for Toxocariasis patient by albendazole therapy. Practical Medicine, 2019, 1123(12):123-6.
[8] Auer H, Walochnik J, Toxocariasis and the clinical spectrum. Adv. Parasitol.,2020, 109:111-30.
[9] Linh DTP, Son LT, Nga DT, Evaluation of several biochemical and hematological index on patients infected by Toxocara spp. larva, Medicine of Ho Chi Minh City, 2013, 17 (supplement edition 1):105-9.
[10] Binh DN, Nam LV, Thang DV et al., Remarks of several biochemical and hematological index and immune on patients infected by Toxocara spp. larva, Military Medicine and Pharmaceutics, 2020, (Special edition):312-8.
[11] Glickman LT, Magnaval JF, Domanski LM, Visceral larva migrans in French adults. A new disease syndrome? Am J Epidemiol., 1987, 125(6):1019-34.